
Daniel BrieCardiovasculare Disease Instiute Timisoara · Interventional Cardiology
Daniel Brie
MD
About
7
Publications
1,582
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
90
Citations
Citations since 2017
Publications
Publications (7)
INTRODUCTION: Pentoxifylline is a xanthine derivative with several potential cardiovascular (CV) benefits, but the evidence regarding its effects on blood pressure (BP) and inflammatory markers such as tumor necrosis factor (TNF-α), C-reactive protein (CRP) and interleukin-6 (IL-6) is not conclusive.
PURPOSE: To evaluate the impact of pentoxifylli...
INTRODUCTION: Pentoxifylline is a xanthine derivative with several potential cardiovascular (CV) benefits, but the evidence regarding its effects on blood pressure (BP) and inflammatory markers such as tumor necrosis factor (TNF-α), C-reactive protein (CRP) and interleukin-6 (IL-6) is not conclusive.
PURPOSE: To evaluate the impact of pentoxifylli...
Introduction: Pentoxifylline is a xanthine derivative with potential cardiovascular benefits.
Aim: To evaluate the impact of pentoxifylline on blood pressure and plasma tumor necrosis factor-α, C-reactive protein and interleukin-6 through a systematic review and meta-analysis of randomized controlled trials.
Methods: The protocol was registered (P...
Today, drug-eluting metal stents are considered the gold standard for interventional treatment of coronary artery disease. While providing inhibition of neointimal hyperplasia, drug-eluting metal stents have many limitations such as the risk of late and very late stent thrombosis, restriction of vascular vasomotion and chronic local inflammatory re...
Background: Several studies suggest similar clinical outcomes between everolimus-eluting bioresorbable stents (BRS) ABSORB (Abbott Vascular, Santa Clara, CA) versus conventional drug-eluting stents (DES) and bare metallic stents (BMS), but the evidence is not definitive. We performed a systematic review and meta-analysis to investigate the effects...
AIMS: Several studies suggest good procedural and similar clinical outcomes between everolimus-eluting bioresorbable stents (BRS) ABSORB versus conventional drug-eluting stents (DES), but the evidence is not definitive. We performed a systematic review and meta-analysis to investigate the effects of BRS versus conventional drug eluting and bare met...
Purpose. Our purpose was to study certain conventional echocardiographic parameters, before and after cardiac resynchronization therapy, in order to establish their importance in the evaluation of therapy results and to create an efficient and non time-consuming patient evaluation protocol. Materials and methods. The standard echocardiographic para...